Sagent Pharmaceuticals Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Sagent Pharmaceuticals

Access the complete profile.

Sagent Pharmaceuticals Fast Facts

Revenue	Over $500 million    See Exact Annual Revenue
Employees	100 - 500Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing
Address	1901 N Roselle Rd Suite 450 Schaumburg, IL 60195

Note: Revenues for privately held companies are statistical evaluations.


Sagent Pharmaceuticals's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Sagent Pharmaceuticals's annual revenues are Over $500 million (see exact revenue data)
• What industry is the company in?
  • Sagent Pharmaceuticals is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Sagent Pharmaceuticals Annual Revenue and Growth Rate

Sagent Pharmaceuticals	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	Over $500 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Sagent Pharmaceuticals's revenues are gauged from an analysis of company filings.

Sagent Pharmaceuticals's Income Statement (based on Industry Averages)

Sagent Pharmaceuticals P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Sagent Pharmaceuticals is developing and marketing. Sagent Pharmaceuticals doesn't have any recent trademark applications, indicating Sagent Pharmaceuticals is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
CAMZAVA pharmaceutical preparations for the treatment of chronic pancreatitis; oral serine protease inhibitor for the treatment of chronic pancreatitis	06/16/2020
REXXREMI Pharmaceutical injectable drugs for the treatment and prevention of Crohn's disease, ulcerative colitis, psoriasis, psoriatic arthritis, ankylosing spondylitis, and rheumatoid arthritis	10/29/2019
REMPARXX Pharmaceutical injectable drugs for the treatment and prevention of Crohn's disease, ulcerative colitis, psoriasis, psoriatic arthritis, ankylosing spondylitis, and rheumatoid arthritis	10/29/2019

See all trademarks and details in the Full Report.

Market Share of Sagent Pharmaceuticals's Largest Competitors

A competitive analysis shows these companies are in the same general field as Sagent Pharmaceuticals, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Sagent Pharmaceuticals. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
SAGENT PHARMACEUTICALS	Schaumburg, IL	100
BIMEDA	Oakbrook Terrace, IL	38
FIRST PRIORITY	Elgin, IL	14
RIPARIAN MANAGEMENT	Addison, IL	1

Future Competition: Sagent Pharmaceuticals's Fastest Growing Competitors

These companies are in the same general field as Sagent Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)